A Case Study on the Intersection of Bioethics and
Regulation
Benjamin Zegarelli, JD, Associate in Health Care and Life Science Practice, New York
office of Epstein Becker Green
ABSTRACT
Although legal analysis does not typically involve bioethical considerations, cutting edge
healthcare products and services involve certain aspects of bioethics and other practical
issues when petitioning FDA or other regulatory agencies. This brief case study
illustrates how these considerations impact a regulatory attorney’s representation of
clients in the healthcare technology space.
BIOGRAPHY
Mr. Zegarelli obtained a Master of Science in Organic Chemistry in 2008 from the
California Institute of Technology and graduated from the School of Law, Yeshiva
University (J.D.) in 2013.He has worked for various entities in the health care industry
and was a research chemist in the Discovery Group of a major research-based
pharmaceutical and health care company, where he developed synthetic routes to
myriad antidepressant/anxiolytic drug candidates. Mr. Zegarelli also previously interned
at the Medicare Rights Center's federal policy office in Washington.
2015 New York State Biotechnology Symposium • May 12 & 13, 2015
At Brookhaven National Laboratory, Upton, NY